According to previous studies, myeloid-leukemia associated mutations occur in addition to BCR::ABL1 in approximately 30% of newly diagnosed CML patients [6–8]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.